Long-Covid Dysphonia
Research type
Research Study
Full title
A multi-centre study evaluating the spectrum of long covid dysphonia
IRAS ID
308767
Contact name
T Ross
Contact email
Sponsor organisation
Royal National Ear Nose and Throat Hospital
Duration of Study in the UK
1 years, 0 months, 1 days
Research summary
Long covid is an evolving syndrome that affects a plethora of bodily systems. There is yet to be a dedicated study to define a global multi-central profile of the effects of long covid on the voice.
This study intends to delineate features of the condition, its severity, impact of quality of life and evaluate risk factors amongst patients presenting to specialist voice clinics. It will provide some granular data detailing specific characteristics of covid dysphonia (voice change). We intend to determine whether there is a standard profile of covid-related voice disorders or different profiles dependent on disease-specific factors. By providing this, this study will aid voice departments (otolaryngologists and voice therapists) in diagnosing and managing the condition. Impact on patients will be determined by the Voice Handicap Index 10 (a validated scoring system to evaluate voice disorders).
Data is to be collected from patients attending voice clinics with dysphonia following covid-19 infection at least five months ago. Recruitment will be led by the Royal National Ear Nose and Throat Hospital, London. A standardised questionnaire will be provided to patients as a one-off means of data collection. No interventions will be required. Data will then be analysed to determine whether there is a standard presentation of the condition or whether indeed a broader range of features are typical in long covid dysphonia. Impact on ensuing management will be discussed.
REC name
South Central - Hampshire A Research Ethics Committee
REC reference
22/SC/0100
Date of REC Opinion
11 Apr 2022
REC opinion
Further Information Favourable Opinion